Biggest stock movers today: Syndax Pharmaceuticals, Coinbase Global and more

1.21BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US87164F1057
CUSIP
87164F105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.17
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.52
Wall Street Target Price
37.27
EPS Estimate Current Year
-1.95
EPS Estimate Next Year
-0.73
EPS Estimate Current Quarter
-0.4365
EPS Estimate Next Quarter
-0.3629
Most Recent Quarter
-
Revenue TTM
252,251,008
Gross Profit TTM
-20,198,000
EBITDA
-194,160,000
Profit Margin
-87.52%
Return On Assets TTM
-18.67%
Return On Equity TTM
-255.93%
Revenue Per Share TTM
2.873
Qtly Revenue Growth YOY
91.80%
Diluted Eps TTM
-2.52
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
4.8321
Price Book MRQ
80.6093
Enterprise Value Revenue
4
Enterprise Value EBITDA
-105
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%